LEADER 01001nam0-22003011i-450- 001 990002067080403321 005 20021010 035 $a000206708 035 $aFED01000206708 035 $a(Aleph)000206708FED01 035 $a000206708 100 $a20021010d--------km-y0itay50------ba 101 0 $aita 200 1 $aUpper permian inozoid, demospongid, and hexactinellid sponges from djebel tebege, tunisia$fJ. Keith Rigby , BabaSenowbari-Daryan 210 $aLawrence$cThe University of Kansas$d1996 215 $a130 p.$d81 tv.$d28 cm 225 1 $aPaleontological Contributions - New series$vN°7 610 0 $aPaleontologia 676 $a560 700 1$aRigby,$bJ. Keith$086913 801 0$aIT$bUNINA$gRICA$2UNIMARC 901 $aBK 912 $a990002067080403321 952 $a61 XIV B. 4B/21$b6078 ( 05/02/1997)$fDAGEN 959 $aDAGEN 996 $aUpper permian inozoid, demospongid, and hexactinellid sponges from djebel tebege, tunisia$9393490 997 $aUNINA DB $aING01 LEADER 02941nam 2200613 a 450 001 9910437854903321 005 20200520144314.0 010 $a1-283-69765-3 010 $a3-642-32841-5 024 7 $a10.1007/978-3-642-32841-1 035 $a(CKB)2670000000279533 035 $a(EBL)1030593 035 $a(OCoLC)818727262 035 $a(SSID)ssj0000796081 035 $a(PQKBManifestationID)11462882 035 $a(PQKBTitleCode)TC0000796081 035 $a(PQKBWorkID)10788967 035 $a(PQKB)10903407 035 $a(DE-He213)978-3-642-32841-1 035 $a(MiAaPQ)EBC1030593 035 $a(PPN)168322854 035 $a(EXLCZ)992670000000279533 100 $a20121027d2013 uy 0 101 0 $aeng 135 $aur|n|---||||| 181 $ctxt 182 $cc 183 $acr 200 10$aLimits of Patentability $eplant sciences, stem cells and nucleic acids /$fAndreas Hubel, Ulrich Storz, Aloys Huttermann 205 $a1st ed. 2013. 210 $aHeidelberg $cSpringer$d2013 215 $a1 online resource (53 p.) 225 0$aSpringerBriefs in biotech patents,$x2192-9904 300 $aDescription based upon print version of record. 311 $a3-642-32840-7 320 $aIncludes bibliographical references. 327 $aPreface -- Andreas Hübel: The Boundaries of Limits - Plant Biosciences -- Ulrich Storz: The Limits of Patentability - Stem Cells -- Aloys Hüttermann: The LImits of Patentability - Genes and Nucleic Acids -- About the Authors. 330 $aSpringerBriefs in Biotech Patents presents timely reports on intellectual properties (IP) issues and patent aspects in the field of biotechnology. In this volume the limits of patentability are addressed, a question that is often raised when it comes to biotechnological inventions: The first section addresses current issues in the patentability of plants produced by essentially biological processes including the controversy between farmer?s privilege and patent exhaustion with respect to seeds in the US. The second section examines the patentability of human embryonic stem cells in Europe and the US, also considering alternative technologies with respect to their practicability and patentability. The third section focuses on the patentability of genes and nucleic acids, especially the issue of patenting of encoding genes and nucleic acids. 410 0$aSpringerBriefs in Biotech Patents,$x2192-9904 606 $aBiotechnology$vPatents 606 $aBiotechnology$xLaw and legislation 615 0$aBiotechnology 615 0$aBiotechnology$xLaw and legislation. 676 $a346.0486 700 $aHubel$b Andreas$01064986 701 $aStorz$b Ulrich$01064618 701 $aHuttermann$b Aloys$01754258 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910437854903321 996 $aLimits of Patentability$94190497 997 $aUNINA